Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 27, 2021

SELL
$0.96 - $1.74 $10,080 - $18,270
-10,500 Closed
0 $0
Q4 2020

Jan 25, 2021

SELL
$0.76 - $1.47 $6,460 - $12,495
-8,500 Reduced 44.74%
10,500 $14,000
Q2 2020

Jul 23, 2020

SELL
$0.52 - $0.92 $2,080 - $3,680
-4,000 Reduced 17.39%
19,000 $15,000
Q1 2020

Apr 30, 2020

BUY
$0.6 - $2.31 $4,800 - $18,480
8,000 Added 53.33%
23,000 $14,000
Q4 2019

Jan 21, 2020

BUY
$0.63 - $2.27 $9,450 - $34,050
15,000 New
15,000 $34,000

Others Institutions Holding MTNB

About Matinas BioPharma Holdings, Inc.


  • Ticker MTNB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,864,992
  • Market Cap $130M
  • Description
  • Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...
More about MTNB
Track This Portfolio

Track Janney Montgomery Scott LLC Portfolio

Follow Janney Montgomery Scott LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.